Markets:

Overview

News

Currencies

International

Treasuries

Deciphera Pharmaceuticals, Inc. - Common Stock (NQ:DCPH)

25.59 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 10, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Deciphera Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)

June 18, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet

June 03, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

May 30, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings) ↗

April 30, 2024

Via Benzinga

May 20, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Squarespace, Inc. (NYSE – SQSP), PlayAGS, Incorporated (NYSE – AGS), HashiCorp Inc. (Nasdaq – HCP), Deciphera Pharmaceuticals, Inc. (Nasdaq – DCPH)

May 13, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Earnings Scheduled For February 6, 2024 ↗

February 06, 2024

Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.

Via Benzinga

Earnings Outlook For Deciphera Pharmaceuticals ↗

February 05, 2024

Via Benzinga

DCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024 ↗

May 10, 2024

DCPH stock results show that Deciphera Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PlayAGS, Incorporated (NYSE - AGS), HashiCorp Inc. (Nasdaq - HCP), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq - TBNK)

May 09, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH

May 01, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HashiCorp Inc. (Nasdaq - HCP), Heartland Financial, USA Inc. (Nasdaq - HTLF), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH), Territorial Bancorp, Inc. (Nasdaq -

April 29, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

S&P 500 Edges Higher; ON Semiconductor Earnings Top Views ↗

April 29, 2024

Via Benzinga

Topics Stocks

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 29, 2024

Via Benzinga

US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday? ↗

April 29, 2024

U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc....

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 29, 2024

Via Benzinga

Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday? ↗

April 29, 2024

ONO Pharmaceutical to acquire Deciphera Pharmaceuticals for $2.4B in cash. Deciphera brings specialized R&D in kinase drug discovery, commercial platforms, and a pipeline of cancer drugs including...

Via Benzinga

Crude Oil Down Over 1%; Deciphera Pharmaceuticals Shares Spike Higher ↗

April 29, 2024

Via Benzinga

Why Is Mullen Automotive (MULN) Stock Up 27% Today? ↗

April 29, 2024

Mullen Automotive stock is climbing higher on Monday with heavy trading of MULN shares alongside it joining a new voucher program.

Via InvestorPlace

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

Citi Just Raised Its Price Target on Shopify (SHOP) Stock ↗

April 29, 2024

Shopify stock is on the rise Monday as shares of SHOP got an increased price target and an upgrade from Citi's analysts this morning.

Via InvestorPlace

Why Is Deciphera Pharmaceuticals (DCPH) Stock Up 72% Today? ↗

April 29, 2024

Deciphera Pharmaceuticals stock is up on Monday after DCPH investors learned of a $2.4 billion acquisition deal with ONO Pharmaceutical.

Via InvestorPlace

Dow Surges Over 100 Points; Domino's Pizza Posts Upbeat Earnings ↗

April 29, 2024

Via Benzinga

Topics Stocks

Deciphera Catapults 72% After Ono Pharmaceutical Agrees To Buy It For $2.4 Billion ↗

April 29, 2024

The company is working on cancer treatments that block problematic kinases by targeting their switch-control pocket.

Via Investor's Business Daily

DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholders

April 29, 2024

From Halper Sadeh LLC

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 29, 2024

Via Benzinga

Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion

April 29, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum

April 09, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences

February 27, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results

February 06, 2024

From Deciphera Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.